Spanish Red Biotech Pipeline

Vivia Biotech

Personalized Medicine Test in Haematological Malignancies

Type: Biomarkers / Diagnostic
Therapeutic area: Cancer
Indication: Multiple Myeloma
Phase: 3Clinical validation, 2Preclinical Validation, 1R+D
Studies location: Europe